Showing results (41-50 of 131) with videos related to
Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|May 14, 2015
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkersZev A Wainberg, Heloisa P Soares, Ravi Patel, et al.Nature Medicine|October 18, 2025
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trialYelena Y Janjigian, Do-Youn Oh, Meredith Pelster, et al.Journal of Surgical Oncology|August 26, 2015
Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative diseaseJennifer L Williams, Andrew H Nguyen, Matthew Rochefort, et al.Cancers|April 13, 2024
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic CancerFaithlore P Gardner, Zev A Wainberg, Christos Fountzilas, et al.Journal of Geriatric Oncology|July 9, 2014
Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysisPeter Ward, J Randolph Hecht, He-Jing Wang, et al.Molecular Cancer Therapeutics|February 12, 2013
Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancerZev A Wainberg, Adrian Anghel, Amy M Rogers, et al.Journal of Geriatric Oncology|January 30, 2014
A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancerArash Naeim, Peter R Ward, Hei-Jing Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal AdenocarcinomaDaniel V T Catenacci, Drew Rasco, Jeeyun Lee, et al.The Oncologist|August 19, 2023
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal CancerEric Van Cutsem, Rona Yaeger, Jean-Pierre Delord, et al.Annals of Surgical Oncology|February 15, 2018
Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic CancerColin M Court, Jacob S Ankeny, Shonan Sho, et al.Pageof 14